In COVID-19 and influenza infections, late peakers in both hepatocellular and cholestatic patterns had an increased risk for adverse outcome of mortality and need for mechanical ventilation (for example, COVID-19 patients with a late rise in ALT have an OR 2.1 (CI 1.6–2.8) for adverse outcome). The gene discussed is GPT; the disease is COVID-19.